Adverse selection
Adverse selection is a term commonly used in economics, insurance, and risk management that describes a situation where the type of risk is not symmetrically known between two parties in a transaction. This concept is particularly prevalent in the insurance industry, where it refers to a scenario where individuals with a higher risk of requiring insurance claim are more likely to purchase insurance than those with a lower risk, leading to an imbalance in the risk pool. This imbalance can result in higher premiums for all insured individuals and can challenge the sustainability of insurance markets.
Overview[edit]
Adverse selection occurs when one party in a transaction has more or better information than the other party. The party with less information is at a disadvantage because they cannot accurately assess the risk of the transaction. In the context of insurance, this means that those with a higher likelihood of filing a claim are more inclined to seek insurance coverage, while those with a lower likelihood may opt out, considering it not cost-effective. This can lead to a disproportionate number of high-risk individuals covered by insurance, increasing the overall costs for the insurer and, consequently, the premiums for all policyholders.
Causes[edit]
The primary cause of adverse selection is information asymmetry. In many transactions, one party often has more or better information about the risk involved. Other factors contributing to adverse selection include lack of transparency, where the details of the risk are not fully disclosed, and behavioral factors, such as individuals' tendency to underestimate their own risk levels.
Examples[edit]
Adverse selection is most commonly associated with the insurance industry, but it can occur in any market where risk is a factor. For example, in the credit market, borrowers who are most likely to default on a loan are often those who seek out the most credit. Similarly, in the used car market (often cited as the "market for lemons" by economist George Akerlof), sellers have more information about the condition of the car than buyers, leading buyers to be wary of high-quality cars being sold for the same price as lower-quality ones.
Mitigation Strategies[edit]
To combat adverse selection, insurers and other market participants employ various strategies. These include:
- Risk Assessment Tools: Improved risk assessment methods, such as genetic testing in life insurance, can help insurers better understand the risk profile of applicants.
- Premium Differentiation: Charging different premiums based on risk factors (e.g., age, smoking status) helps to ensure that those who pose a higher risk pay more.
- Mandatory Coverage: Laws requiring all individuals to purchase insurance can help to mitigate adverse selection by ensuring that low-risk individuals remain in the pool.
- Information Disclosure: Encouraging transparency and full disclosure of relevant information can help to reduce information asymmetry.
Impact[edit]
The impact of adverse selection can be significant, leading to market inefficiency and even market failure if left unchecked. It can result in higher costs, reduced availability of insurance, and can discourage low-risk individuals from participating in the market. In extreme cases, it can lead to a "death spiral," where only the highest risk individuals remain insured, driving up costs further and further.
Conclusion[edit]
Adverse selection is a critical concept in understanding market dynamics, especially in sectors where risk and information asymmetry play significant roles. By employing effective mitigation strategies, markets can reduce the negative impacts of adverse selection and ensure more stable and equitable outcomes for all participants.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian